NDC 50090-6182
STEGLATRO
Ertugliflozin
STEGLATRO is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Ertugliflozin Pidolate.
| Product ID | 50090-6182_62ebce91-1a76-4c3b-bc52-4953699e116c |
| NDC | 50090-6182 |
| Product Type | Human Prescription Drug |
| Proprietary Name | STEGLATRO |
| Generic Name | Ertugliflozin |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-12-19 |
| Marketing Category | NDA / |
| Application Number | NDA209803 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | ERTUGLIFLOZIN PIDOLATE |
| Active Ingredient Strength | 5 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
Packaging
NDC 50090-6182-0
90 TABLET, FILM COATED in 1 BOTTLE (50090-6182-0)
| Marketing Start Date | 2022-10-20 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Drug Details
NDC Crossover Matching brand name "STEGLATRO" or generic name "Ertugliflozin"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0006-5363 | STEGLATRO | ertugliflozin |
| 0006-5364 | STEGLATRO | ertugliflozin |
| 50090-6182 | STEGLATRO | ertugliflozin |
| 50090-6183 | STEGLATRO | ertugliflozin |
Trademark Results [STEGLATRO]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 STEGLATRO 86576333 5498114 Live/Registered |
Merck Sharp & Dohme Corp. 2015-03-25 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.